Stephanie Sánchez-Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Stephanie Sánchez-Torres has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Ibáñez-Contreras
Investigación Biomédica Aplicada S.A.S. de C.V., CDMX, Mexico City 14240, Mexico
1 shared publication - Araceli Diaz-Ruiz
Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City 14269, Mexico
1 shared publication - Axayacatl Morales-Guadarrama
Electrical Engineering Department, Universidad Autónoma Metropolitana, Iztapalapa, Mexico City 09340, Mexico
1 shared publication - Braulio Hernández‐Godínez
Investigación Biomédica Aplicada S.A.S. de C.V., CDMX, Mexico City 14240, Mexico
1 shared publication - Camilo Ríos
Research Direction, National Institute of Rehabilitation, Mexico City 14389, Mexico
1 shared publication - Guillermo Jesus Cruz
Departamento de Física, Instituto Nacional de Investigaciones Nucleares, Axapusco 52750, Mexico
1 shared publication
Latest Publications
- Open Access
Evolution of Spinal Cord Transection of Rhesus Monkey Implanted with Polymer Synthesized by Plasma Evaluated by Diffusion Tensor Imaging
In spinal cord injury (SCI) there is damage to the nervous tissue, due to the initial damage and pathophysiological processes that are triggered subsequently. There is no effective therapeutic strategy for motor functional recovery derived from the injury. Several studies have demonstrated neurons growth in cell cultures on polymers synthesized by plasma derived from pyrrole, and the increased recovery of motor function in rats by implanting the polymer in acute states of the SCI in contusion and transection models. In the process of transferring these advances towards humans it is recommended to test in mayor species, such as nonhuman primates, prioritizing the use of non-invasive techniques to evaluate the injury progression with the applied treatments. This work shows the ability of diffusion tensor imaging (DTI) to evaluate the evolution of the SCI in nonhuman primates through the fraction of anisotropy (FA) analysis and the diffusion tensor tractography (DTT) calculus. The injury progression was analysed up to 3 months after the injury day by FA and DTT. The FA recovery and the DTT re-stabilization were observed in the experimental implanted subject with the polymer, in contrast with the non-implanted subject. The parameters derived from DTI are concordant with the histology and the motor functional behaviour.
Open AccessEvolution of Spinal Cord Transection of Rhesus Monkey Implanted with Polymer Synthesized by Plasma Evaluated by Diffusion Tensor Imaging
In spinal cord injury (SCI) there is damage to the nervous tissue, due to the initial damage and pathophysiological processes that are triggered subsequently. There is no effective therapeutic strategy for motor functional recovery derived from the injury. Several studies have demonstrated neurons growth in cell cultures on polymers synthesized by plasma derived from pyrrole, and the increased recovery of motor function in rats by implanting the polymer in acute states of the SCI in contusion and transection models. In the process of transferring these advances towards humans it is recommended to test in mayor species, such as nonhuman primates, prioritizing the use of non-invasive techniques to evaluate the injury progression with the applied treatments. This work shows the ability of diffusion tensor imaging (DTI) to evaluate the evolution of the SCI in nonhuman primates through the fraction of anisotropy (FA) analysis and the diffusion tensor tractography (DTT) calculus. The injury progression was analysed up to 3 months after the injury day by FA and DTT. The FA recovery and the DTT re-stabilization were observed in the experimental implanted subject with the polymer, in contrast with the non-implanted subject. The parameters derived from DTI are concordant with the histology and the motor functional behaviour.